Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net income	$ 5,170	$ 143,973
Adjustments to reconcile net income to net cash provided by operating activities:
Net impairments recognized in earnings		160
Recovery of provision for loan losses		(8)
Valuation allowance on loans held-for-sale	(1,800)
Unrealized gain on investments at fair value	(4,000)
Gain on extinguishment of debt	(38)
Fair value adjustment on investment in CT Legacy Asset		(7,657)
Gain on deconsolidation of subsidiary		(146,380)
Income from equity investments in unconsolidated subsidiaries		(901)
Distributions of income from unconsolidated subsidiaries		1,710
Distributions from CT Legacy Asset		6,634
Non-cash compensation expense	1,586	504
Amortization of premiums/discounts on loans and securities and deferred interest on loans	(434)	(393)
Amortization of deferred gains and losses on settlement of swaps		(56)
Amortization of deferred financing costs and premiums/discounts on debt obligations	401	9,846
Loss on interest rate swaps not designated as cash flow hedges	4	2,772
Changes in assets and liabilities, net:
Deferred origination fees and other revenue	4,219
Accrued interest receivable	1,309	(3,785)
Deferred income taxes		(1,458)
Prepaid expenses and other assets	896	2,622
Accounts payable and accrued expenses	1,289	(1,075)
Net cash provided by operating activities	8,602	6,508
Cash flows from investing activities:
Origination/purchase of loans receivable	(756,638)
Principal collections and proceeds from securities	349	28,122
Principal collections of loans receivable	96,546	83,245
Contributions to unconsolidated subsidiaries		(4,030)
Distributions from unconsolidated subsidiaries		677
Increase in restricted cash	(7,726)	(2,448)
Net cash (used in) provided by investing activities	(667,469)	105,566
Cash flows from financing activities:
Borrowings under repurchase obligations	216,464	123,977
Repayments under repurchase obligations	(71,439)	(58,464)
Repayments under mezzanine loan		(63,000)
Repayment of securitized debt obligations	(64,674)	(114,768)
Payment of deferred financing costs	(2,175)
Contributions from non-controlling interests	15,000
Purchase of and distributions to non-controlling interests	(17,672)	(8)
Settlement of interest rate swaps	(6,123)
Vesting of restricted class A common stock		(25)
Proceeds from issuance of common stock	633,810
Net cash provided by (used in) financing activities	703,191	(112,288)
Net increase (decrease) in cash and cash equivalents	44,323	(214)
Cash and cash equivalents at beginning of period	15,423	34,818
Cash and cash equivalents at end of period	59,746	34,604
Supplemental disclosure of cash flows information
Payments of interest	(1,434)	(17,105)
Payments of income taxes	(410)	(1,119)
Supplemental disclosure of non-cash investing and financing activities
(Consolidation) deconsolidation of subsidiaries	$ (38,913)	$ 122,308